156 related articles for article (PubMed ID: 36404484)
21. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
22. News on infantile haemangioma. Part 2: therapy and evaluation.
Saerens J; De Leye H; Janmohamed SR
Clin Exp Dermatol; 2021 Apr; 46(3):480-486. PubMed ID: 33539606
[TBL] [Abstract][Full Text] [Related]
23. Propranolol Use for Infantile Hemangiomas.
Ryan J
Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
[No Abstract] [Full Text] [Related]
24. Treatment of infantile hemangiomas with beta-blockers: a review.
Shah S; Frieden IJ
Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population.
Harris J; Phillips JD
Ear Nose Throat J; 2021 Jun; 100(5):NP242-NP245. PubMed ID: 31565986
[TBL] [Abstract][Full Text] [Related]
26. Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.
Tang YJ; Zhang ZZ; Chen SQ; Chen SM; Li CJ; Chen JW; Yuan B; Xia Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):759-762. PubMed ID: 26489635
[TBL] [Abstract][Full Text] [Related]
27. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
[TBL] [Abstract][Full Text] [Related]
28. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
29. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
30. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
31. Review of topical beta blockers as treatment for infantile hemangiomas.
Painter SL; Hildebrand GD
Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
[TBL] [Abstract][Full Text] [Related]
32. Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?: A cohort study.
Raphael MF; Breugem CC; Vlasveld FA; de Graaf M; Slieker MG; Pasmans SG; Breur JM
J Am Acad Dermatol; 2015 Mar; 72(3):465-72. PubMed ID: 25592625
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
34. Infantile hemangioma. Part 2: Management.
Sebaratnam DF; Rodríguez Bandera AL; Wong LF; Wargon O
J Am Acad Dermatol; 2021 Dec; 85(6):1395-1404. PubMed ID: 34419523
[TBL] [Abstract][Full Text] [Related]
35. Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants.
Frongia G; Byeon JO; Arnold R; Mehrabi A; Günther P
World J Pediatr; 2018 Jun; 14(3):254-258. PubMed ID: 29796952
[TBL] [Abstract][Full Text] [Related]
36. Infantile hemangiomas: risk factors for complications, recurrence and unaesthetic sequelae.
Mariani LG; Ferreira LM; Rovaris DL; Bonamigo RR; Kiszewski AE
An Bras Dermatol; 2022; 97(1):37-44. PubMed ID: 34848114
[TBL] [Abstract][Full Text] [Related]
37. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Lee JC; Modiri O; England RW; Shawber CJ; Wu JK
Plast Reconstr Surg; 2021 Apr; 147(4):875-885. PubMed ID: 33776033
[TBL] [Abstract][Full Text] [Related]
38. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
[TBL] [Abstract][Full Text] [Related]
39. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
40. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
